Enterococcus faecium has recently emerged as a serious nosocomial pathogen. The prevalence and severity of enterococcal infections, the mortality rate from such infections, and the antibiotic resistance of enterococci are often species dependent. Since conventional biochemical methods fail to differentiate E. faecium from certain newly described enterococcal species, a PCR-based assay was developed for the rapid identification of E. faecium.
Enterococcus faecium accounts for 5 to 16% of enterococci isolated from human infections and is second only to E. faecalis as the most common Enterococcus species associated with nosocomial infections (10, (13) (14) (15) . It is also one of the most phenotypically heterogeneous of all the enterococcal species (19) and has been reported to have a tendency for the acquisition of resistance to multiple antimicrobial agents (1, 18) . Increasingly, strains of E. faecium have been reported to possess high-level resistance to aminoglycosides, penicillin, and vancomycin (9) .
The phenotypic and biochemical similarities between many enterococci have made species identification a challenging undertaking. Misidentifications of E. faecium clinical isolates as E. durans (12, 16) or E. gallinarum (4) by automated systems or by conventional biochemical tests have been reported. Species identification and antimicrobial susceptibility profiles are necessary for recognizing colonization and infection patterns and analysis of epidemiologic data. Unequivocal species identification of an atypical clinical isolate can be complex, time-consuming, and expensive and can take several days to accomplish. Several studies have addressed the problem of species identification for E. faecium. Those studies have used various techniques including analysis of whole-cell protein profiles by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (6), DNA hybridization and contour-clamped homogeneous field electrophoresis (4), PCR amplification of the D-Ala:D-Ala ligase gene (5) , and DNA hybridization in combination with pulsed-field gel electrophoresis (2) . Since misidentification of most enterococcal species has involved E. faecium, the objective of this study was to develop an unequivocal and rapid PCR-based assay to positively identify E. faecium.
Clinical isolates of enterococci were collected from nosocomial outbreaks in the United States. Conventional identification was performed with the gram-positive identification (GPI) card (Bio-Merieux-Vitek, Inc., Hazelwood, Mo.) by using the automicrobic system, the RapID STR System (Innovative Diagnostic System, Norcross, Ga.), and biochemical tests (8) such as yellow pigment production, motility, growth on 6.5% NaCl and/or bile esculin, leucine aminopeptidase activity, pyrrolidonyl peptidase activity, and utilization of mannitol, sorbitol, arabinose, raffinose, sucrose, ribose, and arginine. Other enterococcal strains used in this investigation were obtained from the American Type Culture Collection (ATCC; Beltsville, Md.).
DNA of E. faecium ATCC 19434 was isolated as described previously (3), except that mutanolysin (Sigma Chemical Co., St. Louis, Mo.) was used to lyse the bacterial cell wall. The DNA was digested with EcoRI, and the restriction fragments were ligated into the unique EcoRI site of the pUC18 plasmid vector. Recombinant plasmids were transformed into E. coli DH5␣ cells (Gibco BRL, Bethesda, Md.) which were inoculated onto Luria-Bertani agar containing 50 g of ampicillin per ml, 50 g of 5-bromo-4-chloro-3-indolyl-␤-D-galactoside per ml, and 1 mM isopropyl-␤-D-thiogalactopyranoside. Recombinant plasmid DNA was isolated from clones by the boiling miniprep procedure (11) . The plasmids were then digested with EcoRI and then electrophoresed in a 1.0% (wt/vol) SeaKem GTG agarose gel (FMC Bioproducts, Rockland, Maine) containing 0.5 g of ethidium bromide per ml. The DNA fragments were visualized on a UV transilluminator. Southern blots (17) of cloned insert DNA molecules were probed with EcoRI-digested E. faecalis ATCC 19433 genomic DNA by using the Genius kit (Boehringer Mannheim Biochemicals). Clones which contained insert DNA that hybridized with the E. faecalis DNA were eliminated, and those which did not were selected as possibly containing E. faeciumspecific insert DNA. Putative E. faecium-specific inserts were then used to probe blots of EcoRI-digested genomic DNA blots of enterococcal reference strains. Southern blots of EcoRI-digested enterococcal DNA were probed in the same manner as the cloned insert DNA. DNA sequencing was accomplished with the DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, Calif.) on a 373A Automatic DNA sequencer (Applied Biosystems). The FASTA program was used to search the GenBank database (release 89.9) for homologous sequences.
PCR amplifications were performed with single colonies of clinical isolates which were scraped from the surface of agar plates and resuspended in 40 l of 5% Chelex (Bio-Rad, Richmond, Calif.). The cell suspension was boiled for 5 min and was centrifuged at 14,000 ϫ g for 2 min. Five microliters of the supernatant was added to 25 l of the PCR mixture. Oligonucleotide primers were selected by using the Oligo (version 4.0) primer analysis software (National Biosciences, Inc., Plymouth, Minn.). A pair of 21-mer primers (EM1A, 5Ј-TTG AGG CAG ACC AGA TTG ACG; EM1B, 5Ј-TAT GAC AGC GAC TCC GAT TCC) was synthesized by Midland Certified Reagents Company (Midland, Tex.). Two-temperature PCRs (7) were performed in a total volume of 25 l containing 10 mM TrisHCl (pH 8.3), 75 mM KCl, 3.5 mM MgCl 2 (Stratagene, La Jolla, Calif.), 200 M (each) deoxynucleoside triphosphate (Boehringer), 1.0 M (each) primer, 0.5 U of Taq DNA polymerase (Perkin-Elmer, Branchburg, N.J.), and 25 ng of DNA template. The amplification was accomplished by predenaturation at 94ЊC for 4 min, followed by 25 cycles of 30 s at 94ЊC and 1 min at 72ЊC, in a Gene Amp PCR System 9600 thermocycler (Perkin-Elmer). An extension step of 8 min at 72ЊC was included after the final cycle. The PCR products were analyzed by electrophoresis on a 1.2% SeaKem GTG agarose gel (FMC Bioproducts).
Recombinant plasmids of several clones of the E. faecium genomic library were found to contain inserts which were specific for E. faecium. The specificity was verified by using their recombinant plasmids as probes against Southern blots of EcoRI-digested genomic DNA of representative enterococcal strains and species. Clone pEM432, which contained a 3.2-kb insert, was observed to hybridize only with genomic DNA from E. faecium ATCC 19434 and ATCC 35667, but not with DNA from other enterococcal species (data not shown). Restriction analysis revealed that two HindIII sites are located in this insert. The pEM432 plasmid was double digested with EcoRI and HindIII, and a resulting 1.2-kb EcoRI-HindIII fragment was subcloned into pUC18. This subclone was termed pEM1225, referring to the number of base pairs found in its insert. No significant homologies were found between the sequence of the 1,225-bp insert and those of other genes found in the GenBank database. Primers EM1A and EM1B, selected from the 1,225-bp fragment, generated a 658-bp DNA product upon PCR amplification of DNA from E. faecium ATCC 19434 and ATCC 35667. No amplification product was found by PCRs of other Enterococcus species (Fig. 1) . A total of 186 clinical isolates of enterococci were collected, and the species were determined by their phenotypic characteristics. All 98 clinical isolates identified as E. faecium by standard biochemical assays yielded the 658-bp amplicon. No amplification was observed with 86 isolates identified as E. faecalis or with 2 known E. casseliflavus strains. DNAs isolated from three E. gallinarum strains, including two nonmotile isolates which were identified as E. faecium by conventional biochemical tests (4), did not generate a PCR product. The 658-bp PCR product was labeled with digoxigenin and was then used for hybridization to Southern blots containing digested genomic DNAs of ATCC enterococcus strains. As expected, only lanes containing E. faecium showed a strong hybridization signal at the position corresponding to the 3.2-kb fragment in pEM432 (data not shown). This further verified the specificity of the PCR assay.
The template DNA used in the amplification reactions was obtained by standard DNA isolation techniques and by release from single colonies by boiling whole cells in 5% Chelex for 5 min. The latter procedure eliminated the time necessary for growth of single-colony inocula in broth and also reduced the time and labor associated with the conventional DNA isolation procedure. By the rapid-release method, the entire PCR assay can be completed in approximately 4 h.
Endogenous multiple-drug-resistant enterococci are a major group of gastrointestinal tract microflora capable of causing serious extraintestinal tract infections, especially in compromised hosts. Conventional biochemical identification of E. faecium is time-consuming, is sometimes inconclusive, and often does not differentiate E. faecium from E. durans, E. casseliflavus, and E. gallinarum. Although biochemical identification can be accomplished in 4 to 8 h by use of the GPI card, many isolates are not conclusively identified by this rapid test. For such isolates, up to 24 to 48 h can be required for further identification assays. Accurate identification can also be confounded because some E. faecalis strains fail to degrade arginine and certain E. faecium isolates ferment sorbitol. Also, motility and pigmentation are not always definitive properties of E. casseliflavus. Thus, a more specific and rapid assay is needed for the identification of E. faecium. Hybridization studies and pulsed-field gel electrophoresis have been used to aid in the identification of atypical enterococcal isolates. However, these methods demand the use of time-consuming and laborintensive procedures such as Southern blotting and the complex procedure of liberating chromosomal DNA from cells in agarose. Identification of E. faecium in stool samples containing mixed bacterial populations is important for proper surveillance, but such a means of identification is often difficult because the colony appearance of E. faecium is similar to that of other enterococci. We have correctly identified E. faecium in simulated mixed cultures of enterococci (data not shown). Although E. casseliflavus and E. gallinarum are not often found in clinical samples, they are increasingly being detected in stool samples in the United States (20) .
The PCR-based diagnostic assay described in this study targets a nucleotide sequence that is strongly conserved in E. faecium. A simple and rapid extraction of template DNA from isolated colonies enables large-scale processing of clinical isolates for routine screening of E. faecium. This test offers a specific technique for the identification of E. faecium within 4 h from the time of isolation of the organism. This assay can also be used to identify E. faecium when biochemical and automated tests yield equivocal data.
Nucleotide sequence accession number. The accession number of the DNA sequence of pEM1225 in GenBank is L78127.
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